Teladoc Health TDOC
Teladoc Health, Inc. · NYSE · Services-Offices & Clinics of Doctors of Medicine
$6.88+6.67%close on Oct. 28, 2026 · volume 8.5M · Yahoo Finance
Price, last 47 sessions
Our coverage
Nothing published yet.
Insider buying and selling
| Date | Insider | Trade | Shares | Avg. price | Value |
|---|---|---|---|---|---|
| Oct. 2, 2026 | Joseph Ronald Catapano Chief Accounting Officer | Sold | 655 | $5.65 | $3,703 |
| Sept. 11, 2026 | Charles Divita III CHIEF EXECUTIVE OFFICER, director | Sold | 17,805 | $6.10 | $108,682 |
| Sept. 3, 2026 | Fernando M. Rodrigues President of BetterHelp | Sold 10b5-1 plan | 9,812 | $6.51 | $63,876 |
| Sept. 2, 2026 | Carlos Nueno President, International | Sold | 6,200 | $6.30 | $39,066 |
| Sept. 2, 2026 | Adam C. Vandervoort CHIEF LEGAL OFFICER, SECRETARY | Sold | 7,573 | $6.30 | $47,717 |
| Sept. 2, 2026 | Kelly Bliss President, U.S. Group Health | Sold | 7,357 | $6.30 | $46,356 |
| Sept. 2, 2026 | Joseph Ronald Catapano Chief Accounting Officer | Sold | 274 | $6.30 | $1,726 |
| Sept. 2, 2026 | Charles Divita III CHIEF EXECUTIVE OFFICER, director | Sold | 18,327 | $6.30 | $115,478 |
| Sept. 2, 2026 | Fernando M. Rodrigues President of BetterHelp | Sold 10b5-1 plan | 5,439 | $6.30 | $34,271 |
Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.
Recent SEC filings
All 18 →Results of operations and financial condition · Financial statements and exhibits
AI summary, unreviewedTeladoc Health Q3 2026 revenue of $605.1 million beats $590.5 million consensus and EPS of -$0.15 beats -$0.19, but FY2026 EPS guidance midpoint of -$0.85 trails -$0.79 consensus
Departure/appointment of directors or officers